CoChat

The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial

Open access

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Homocysteine has been postulated as a novel, potentially reversible risk factor for osteoporosis and related fractures. We evaluated whether homocysteine-lowering therapy with B-vitamins in patients with symptomatic cerebrovascular disease reduced the incidence of osteoporotic fractures. METHODS: VITAmins To Prevent Stroke (VITATOPS) was a prospective randomised double-blind placebo-controlled trial in which 8,164 patients with recent (within 7 months) stroke or transient ischemic attack were randomly allocated to double-blind treatment with one tablet daily of either placebo (n = 4,075) or B-vitamins (folic acid 2 mg, vitamin B6 25 mg, vitamin B12 500 μg; n = 4,089). Patients were reviewed every six months. Any osteoporotic fracture and osteoporotic hip fractures were secondary outcome events, and were reviewed by a masked adjudication committee. Analysis was by intention to treat. Logistic regression was used to identify independent predictors of fracture. RESULTS: Participants had a mean age of 62.6 years (SD 12.5 years) and 64% were male, 42% of Western European descent and 75% were functionally independent (Oxford Handicap Scale of two or less). After a median duration of 2.8 years therapy and 3.4 years follow-up, there was no significant difference in the incidence of any osteoporotic fracture between participants assigned B-vitamins (67 [1.64%]) and placebo (78 [1.91%]; risk ratio [RR] 0.86, 95% confidence interval [CI] 0.62-1.18) or the incidence of hip fractures (34 [0.83%] B-vitamins vs. 36 [0.88%] placebo; RR 0.94, 95% CI 0.59-1.5). There was no significant impact of B-vitamin therapy on time to first fracture. Baseline homocysteine levels did not predict any osteoporotic fracture (p =0.43). Independent predictors of any osteoporotic fracture were female sex, age > 64 years, Western European ethnicity and use of anti-osteoporosis medication at randomization (all p < 0.01). CONCLUSIONS: Once daily treatment with B-vitamins had no effect on incidence of osteoporotic fractures during a median of 3.4 years follow-up in patients with cerebrovascular disease. A modest effect of B-vitamin therapy is not excluded due to the low numbers of fracture outcome events.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2318-13-88

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Kaplan Meier estimates of any osteoporotic fracture outcomes.
Figure 1 Kaplan Meier estimates of any osteoporotic fracture outcomes.CC BY · PubMed Central
Figure 2 Kaplan Meier estimates of osteoporotic hip fracture outcomes.
Figure 2 Kaplan Meier estimates of osteoporotic hip fracture outcomes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 30 references

Cited by

See all 43

Metadata

Authors
Gommans, J., Yi, Q., Eikelboom, J. W., Hankey, G. J., Chen, C., & Rodgers, H.
Affiliations
  • Hawke's Bay Hospital (NZ)
  • Canadian Blood Services (CA)
  • McMaster University (CA)
  • The University of Western Australia (AU)
  • National University of Singapore (SG)
  • Newcastle University (GB)
Corresponding author
Gommans, John
Venue
BMC Geriatrics
Published
2013-09-03
Volume
13
Issue
1
Pages
88-88
ISSN
1471-2318 (ISSN-L)
OpenAlex
W2015427312
Cited by
42
References
30
Citations by year
2025: 1 · 2024: 4 · 2022: 2 · 2021: 3 · 2020: 7 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 2 · 2015: 9 · 2014: 2
FWCI
3.56
Type
journal article
Language
en
Open access
Locations
  • BMC Geriatrics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by)
Funders
  • Royal Perth Hospital Medical Research Foundation
  • National Institute for Health and Care Research (NF-SI-0507-10249)
  • National Heart Foundation of Australia
  • Medical Research Council
  • National Health and Medical Research Council
  • National Medical Research Council
  • Biomedical Research Council
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
homocysteine, vitamin B supplementation, folic acid, vitamin B6, vitamin B12, osteoporotic fractures, hip fracture, cerebrovascular disease, stroke, transient ischemic attack, fracture risk factors, osteoporosis drugs, fracture prevention, sex differences, ethnicity, age, time to fracture
MeSH terms
Aged, Cerebrovascular Disorders, Double-Blind Method, Female, Follow-Up Studies, Homocysteine, Humans, Male, Middle Aged, Prospective Studies, Vitamin B Complex, Biomarkers, Treatment Outcome, Stroke, Osteoporotic Fractures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial. https://app.cochat.ai/papers/10.1186/1471-2318-13-88
The paper
Gommans, J., Yi, Q., Eikelboom, J. W., Hankey, G. J., Chen, C., & Rodgers, H. (2013). The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial. BMC Geriatrics. https://doi.org/10.1186/1471-2318-13-88

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.